Advanced Immunological Treatment and Research Medical Center

Nobel Prize Winning Immunologist Joins Batu Biologics in Quest to “Starve the Tumor”


CHIPSA is excited to announce that 2011 Nobel prize winner Bruce Beutler has joined the board of one of our key collaborators, Batu Biologics. CHIPSA has been on the forefront of immunotherapy for nearly 38 years and the addition to Dr. Beutler on the Scientific Advisory board of Batu is another signal that Immunotherapy is a mainstay in cancer treatment.

I am excited to work alongside the team assembled by Samuel Wagner and provide advice towards the development of new therapeutic approaches to the treatment of cancer.” - Dr. Bruce Beutler

“I am excited to work alongside the team assembled by Samuel Wagner and provide advice towards the development of new therapeutic approaches to the treatment of cancer.” - Dr. Bruce Beutler


CHIPSA is focused on collaborating with the top scientists in the world to develop cutting edge approaches to better treat cancer. Just this year we formed our scientific advisory board which included the former chief of immunogenetics of the NIH, Dr. Francesco Marincola.

The 38 years of immunotherapy experience has put CHIPSA in a unique position because most doctors and hospitals are very new to this approach. CHIPSA has been combining natural therapies along with man made medications to stimulate the immune system for nearly 40 years.

Our patients and result are currently being studied. The last peer reviewed patient retrospective study CHIPSA did in 1995 showed CHIPSA melanoma patients beating standard of care by over 600%. This was before many of the treatments that we have today.

CHIPSA is in the process of interviewing 20 previous patients that were given a terminal diagnosis that are over 15 years out from their diagnosis. The patients were considered to have a “spontaneous remission” by the scientific community. 

Collaborations with scientists like Dr. Beutler and biotech companies like Batu Biologics allow us to further build bridges in the search for a cure for cancer.